This Tier 1 Canada Research Chair (CRC) in “Multimodality Molecular Imaging” aligns with uOttawa’s Transformation 2030 Strategic Research Plan (SRP), particularly with the Enabling lifelong health and wellness Strategic Area of Research (SAR), under “Brain and Mental Health”, “Vascular and Cardiovascular Health”, and Infection, Immunity and Inflammation”. It also contributes to the Creating a sustainable environment SAR through the “Emerging materials and nanotechnology” theme. Additionally, this CRC supports the Faculty of Science SRP within the “Dynamics and molecules of Life” strategic area.
This CRC positions uOttawa as leader in advancing personalized medicine through innovative, non-invasive and clinically relevant diagnostics, reinforcing our national and international reputation. It will increase the visibility of our graduate and undergraduate programs, attracting students to this critical, interdisciplinary field. With a cross-cutting, multidisciplinary approach, this CRC in Multimodality Molecular Imaging will serve as a nucleus for growth and leadership within the broader institution (i.e. across Faculties and research Hospitals), bridging Science and Medicine through essential integration with synthetic and radiochemistry, biochemistry, radiology, and medical physics.
The rapid expansion of molecular imaging and nuclear medicine has created large voids in the labour market for well-trained HQP to complement the growing radiopharmaceutical sector. Over a five-year period, there is a projected need for 40 master-level graduates and 240 PhD-level graduates in the US. Ontario, and Ottawa in particular, are well positioned to meet this need by delivering industry-directed training with local partners such as The Centre for Probe Development and Commercialization, CNL Chalk River, Nordion and BWXT, and provide practical directed experience. The proposed CRC program will support HQP development to meet local and national labour demands, further enhancing Ottawa’s leadership in radiochemistry and molecular imaging innovation.
Tier 1 Chairs, tenable for seven years and renewable once, are for outstanding researchers acknowledged by their peers as world leaders in their fields. For each Tier 1 Chair, the institution receives $200,000 annually for seven years. Nominees for Tier 1 Chair positions must be full professors or associate professors who are expected to be promoted to the full professor level within one or two years of the nomination. Alternatively, if they come from outside the academic sector, nominees must possess the necessary qualifications to be appointed at these levels. New CRC nominees are also eligible for infrastructure support from the Canada Foundation for Innovation (CFI) to help acquire state-of-the-art equipment essential to their work.